TATACHEMNSEQ4FY25May 7, 2025

Tata Chemicals Limited

2,859words
1turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
ied. Important factors that could make a difference to the Company’s operations include, among others, economic conditions affecting demand / supply, price conditions in the domestic and overseas market
₹ 3,509
d Salt) 1,375 Kts vs. 1,334 Kts (PQ) 5,404 Kts (CY) vs. 5,196 Kts (PY) 1,396 Kts (PY) Revenue ₹ 3,509 Cr (CQ) vs. ₹ 3,590 Cr (PQ) Revenue ₹ 14,887 Cr (CY) vs. ₹15,421 Cr (PY) ₹ 3,475 Cr (PY) EBITDA
₹ 3,590
s. 1,334 Kts (PQ) 5,404 Kts (CY) vs. 5,196 Kts (PY) 1,396 Kts (PY) Revenue ₹ 3,509 Cr (CQ) vs. ₹ 3,590 Cr (PQ) Revenue ₹ 14,887 Cr (CY) vs. ₹15,421 Cr (PY) ₹ 3,475 Cr (PY) EBITDA ₹ 327 Cr (CQ) vs. ₹
₹ 14,887
ts (CY) vs. 5,196 Kts (PY) 1,396 Kts (PY) Revenue ₹ 3,509 Cr (CQ) vs. ₹ 3,590 Cr (PQ) Revenue ₹ 14,887 Cr (CY) vs. ₹15,421 Cr (PY) ₹ 3,475 Cr (PY) EBITDA ₹ 327 Cr (CQ) vs. ₹ 434 Cr (PQ) ₹ 443 Cr (PY
₹15,421
(PY) 1,396 Kts (PY) Revenue ₹ 3,509 Cr (CQ) vs. ₹ 3,590 Cr (PQ) Revenue ₹ 14,887 Cr (CY) vs. ₹15,421 Cr (PY) ₹ 3,475 Cr (PY) EBITDA ₹ 327 Cr (CQ) vs. ₹ 434 Cr (PQ) ₹ 443 Cr (PY) PAT* ₹ (12) Cr (
₹ 3,475
(PY) Revenue ₹ 3,509 Cr (CQ) vs. ₹ 3,590 Cr (PQ) Revenue ₹ 14,887 Cr (CY) vs. ₹15,421 Cr (PY) ₹ 3,475 Cr (PY) EBITDA ₹ 327 Cr (CQ) vs. ₹ 434 Cr (PQ) ₹ 443 Cr (PY) PAT* ₹ (12) Cr (CQ) vs. ₹ 49 Cr (P
₹ 327
r (CQ) vs. ₹ 3,590 Cr (PQ) Revenue ₹ 14,887 Cr (CY) vs. ₹15,421 Cr (PY) ₹ 3,475 Cr (PY) EBITDA ₹ 327 Cr (CQ) vs. ₹ 434 Cr (PQ) ₹ 443 Cr (PY) PAT* ₹ (12) Cr (CQ) vs. ₹ 49 Cr (PQ) ₹ 145 Cr (PY) EB
₹ 434
Cr (PQ) Revenue ₹ 14,887 Cr (CY) vs. ₹15,421 Cr (PY) ₹ 3,475 Cr (PY) EBITDA ₹ 327 Cr (CQ) vs. ₹ 434 Cr (PQ) ₹ 443 Cr (PY) PAT* ₹ (12) Cr (CQ) vs. ₹ 49 Cr (PQ) ₹ 145 Cr (PY) EBITDA ₹ 1,953 Cr (C
₹ 443
e ₹ 14,887 Cr (CY) vs. ₹15,421 Cr (PY) ₹ 3,475 Cr (PY) EBITDA ₹ 327 Cr (CQ) vs. ₹ 434 Cr (PQ) ₹ 443 Cr (PY) PAT* ₹ (12) Cr (CQ) vs. ₹ 49 Cr (PQ) ₹ 145 Cr (PY) EBITDA ₹ 1,953 Cr (CY) vs. ₹ 2,847 C
₹ 49
₹ 3,475 Cr (PY) EBITDA ₹ 327 Cr (CQ) vs. ₹ 434 Cr (PQ) ₹ 443 Cr (PY) PAT* ₹ (12) Cr (CQ) vs. ₹ 49 Cr (PQ) ₹ 145 Cr (PY) EBITDA ₹ 1,953 Cr (CY) vs. ₹ 2,847 Cr (PY) PAT* ₹ 479 Cr (CY) vs. ₹ 1,310
₹ 145
Y) EBITDA ₹ 327 Cr (CQ) vs. ₹ 434 Cr (PQ) ₹ 443 Cr (PY) PAT* ₹ (12) Cr (CQ) vs. ₹ 49 Cr (PQ) ₹ 145 Cr (PY) EBITDA ₹ 1,953 Cr (CY) vs. ₹ 2,847 Cr (PY) PAT* ₹ 479 Cr (CY) vs. ₹ 1,310 Cr (PY) Net Deb
₹ 1,953
Q) vs. ₹ 434 Cr (PQ) ₹ 443 Cr (PY) PAT* ₹ (12) Cr (CQ) vs. ₹ 49 Cr (PQ) ₹ 145 Cr (PY) EBITDA ₹ 1,953 Cr (CY) vs. ₹ 2,847 Cr (PY) PAT* ₹ 479 Cr (CY) vs. ₹ 1,310 Cr (PY) Net Debt (incl of lease) ₹ 5,51
Guidance — 1 items
Notes
opening
in TN and Mambattu, Tirupati Dist, AP (Cumulative 4,80,000 in two years) • 3,30,000 Mangroves planted across Sundarbans, Cuddalore, Pulicat Lake and Jamnagar in FY25 (Cumulative 5,10,000) • 29 Whale Sharks rescued in FY25 off the coast of Saurashtra region of Gujarat (Cumulative 974 since start of the project) • 3 season biodiversity impact assessment initiated in Mithapur.
Speaking time
Notes
1
Opening remarks
Notes
• Above financials are for Continuing Operations • Consolidated financials is after adjusting SPV & other adjustments • Rallis financials represent 100% share. Consolidated numbers is after adjustment of Rallis India’s NCI. 1. Before exceptional items and after JV share 2. Before exceptional items and NCI 3. After exceptional items and NCI Revenues EBITDA Exceptional Items Share of JV Income PBT1 PAT2 PAT3 Units ₹ Crore Revenues EBITDA Exceptional Items Share of JV Income PBT1 PAT2 PAT3 Balance Sheet As on March 2025 Non - Current Assets Inventories Investments Trade Receivables Cash and Bank Balance Others Current Assets Total Assets Equity & Reserves Non - Controlling Interests Non-Current Liabilities Borrowings (Non-Current)/ Lease Liabilities Borrowings (Current)/ Lease Liabilities Trade Payables Others Current Liabilities Total Liabilities Particulars Consolidated (₹ Cr) Standalone (₹ Cr) 31-Mar-25 31-Mar-24 31-Mar-25 31-Mar-24 31,060 30,389 20,778 19,047 2,558 805 1,900 615 842 3
← All transcriptsTATACHEM stock page →